Breast Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People diagnosed with triple negative breast cancer (a type of breast cancer that tests negative for certain proteins: ER, PR, and HER2, or where ER is found in less than 10% of cells).
• People who have completed at least 8 weeks of chemotherapy given before surgery (called neoadjuvant chemotherapy).
• People who are waiting for surgery and whose scans or physical examination show signs that some cancer may still be present, as determined by their treating doctor.
• People who have already had surgery and whose tissue sample examined in a lab confirmed that some cancer remained after surgery.
• People who are able to attend clinic appointments within 6 weeks after surgery and for the following 6 months.
• People who are willing to provide a series of blood samples during the study.
• People who are able to follow the study schedule, including appointments, tests, and other study requirements.

Who may not be able to join:

• People whose cancer has spread to other parts of the body (metastatic disease), based on physical examination or scans.
• People whose breast cancer has come back after a previous diagnosis (a recurrence).
• People who have not had chemotherapy before surgery, or who had less than 8 weeks of it.
• People who received radiation treatment before their surgery.
• People who are not able to sign or understand the consent form for the study.
• People with a known HIV or hepatitis infection.

Important: Always verify eligibility with the trial site directly before applying.